huberman bpc 157 NEW podcast episode is up! Dr. Andrew — Peptides, Performance, and Protocols Andrew Huberman, Ph.D., is a neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at BPC-157 | Ask Huberman Lab

Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption

Were committed to providing information that is up-to-date, accurate, and relies on evidence-based research and peer-reviewed journals

GHK-Cu stimulates collagen synthesis and skin remodeling

Tirzepatide : Helps regulate blood sugar and support weight loss

He completed his Dermatology residency at Rush University in Chicago, where he served as chief resident

High-dose oral treatment is effective and is increasingly popular